Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Breast cancer patients may have better option to reduce oestrogen levels

Dr Stephen Jones - Director of US Oncology Research Inc, Texas
Breast cancer patients may have better option to reduce oestrogen levels ( Dr Stephen Jones - Director of US Oncology Research Inc, Texas )
11 Mar 2009

Use of written forms doubles breast cancer detection rate

Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medical Center Research Institute
Use of written forms doubles breast cancer detection rate ( Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medical Center Research Institute )
11 Mar 2009

Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy

Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital )
9 Mar 2009

Poor prognosis on small, HER2 positive tumours

Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center
Poor prognosis on small, HER2 positive tumours ( Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D.  Anderson Cancer Center )
9 Mar 2009

Azacitidine for Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Azacitidine for Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Effects of Myelodysplastic Syndrome

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Effects of Myelodysplastic Syndrome ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

How azacitidine works

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
How azacitidine works ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

Myelodysplastic Syndromes and Acute Myeloid Leukaemia

Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York
Myelodysplastic Syndromes and Acute Myeloid Leukaemia ( Dr Lewis Silverman - Myelodysplastic Syndrome & Myeloproliferative Disease Center, New York )
19 Feb 2009

ECCO 15 - ESMO 34 Executive Scientific Programme Committee

ECCO-ESMO Roundtable discussion - Full Version
ECCO 15 - ESMO 34 Executive Scientific Programme Committee ( ECCO-ESMO Roundtable discussion - Full Version )
16 Feb 2009

Winners from the UICC's Cancer Film Festival

Reel Lives: Cancer Chronicles
Winners from the UICC's Cancer Film Festival ( Reel Lives: Cancer Chronicles )
3 Feb 2009

Complex Events and Emergence in Cancer Systems

Dr Sylvia Nagl, University College London
Complex Events and Emergence in Cancer Systems ( Dr Sylvia Nagl, University College London )
28 Jan 2009

Clinical Requirements Regarding In Silico Oncology

Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland
Clinical Requirements Regarding In Silico Oncology ( Professor Norbert Graf, Director of Oncology and Haematology Clinic, University of Saarland )
23 Jan 2009